"
Team:UCL/Practice
From 2013.igem.org
(Difference between revisions)
| Line 76: | Line 76: | ||
<p class="abstract_title">Overview</p> | <p class="abstract_title">Overview</p> | ||
<p class="abstract_text"> | <p class="abstract_text"> | ||
| - | In our human practices, we aim to not only consider the implication of our proposed treatments for Alzheimer’s patients and AD as a disease, but to also explore other possibilities in neuro-genetic engineering, consider the ‘neuro-ethicality’ and social | + | In our human practices, we aim to not only consider the implication of our proposed treatments for Alzheimer’s patients and AD as a disease, but to also explore other possibilities in neuro-genetic engineering, consider the ‘neuro-ethicality’ and social... |
</p> | </p> | ||
</a> | </a> | ||
Revision as of 21:57, 14 August 2013
XXXXXXX
YYYYYYYY
Over the last decade there has been mounting public interest in genetic engineering and the potential and pitfalls of associated emerging technologies. These technologies promise much, potentially even treatments for brain diseases, such as Alzheimer's disease, and yet genetic modification of the brain is something many would feel uneasy about, despite the horrors it tries to mitigate. 'Neuro-genetic engineering' may slip over into other areas, including psychological therapy and cognitive enhancements, changing the way society views its minds forever.
Click the abstracts below to read more.
